AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 5 946-R952, Copyright © 1991 by American Physiological Society

ARTICLES

Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion

E. Grossman, P. C. Chang, A. Hoffman, M. Tamrat, I. J. Kopin and D. S. Goldstein
Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

The rate of appearance of the sympathetic neurotransmitter norepinephrine (NE) in the regional venous drainage (NE spillover) can be estimated based on intravenous or intra-arterial infusions of [3H]NE. The present study examined whether forearm NE spillover (FASO) in humans depends on forearm blood flow (FBF) and on the site of infusion of the tracer. Healthy volunteers underwent infusions of [3H]NE and [3H]isoproterenol (Iso) administered intravenously (n = 21), intra-arterially (n = 32), or by both routes in the same experimental session (n = 7). FBF was manipulated by intra-arterial infusions of the vasodilator sodium nitroprusside (n = 7) or the vasoconstrictor methoxamine (n = 7). Forearm extraction percents of [3H]NE exceeded those of [3H]Iso in all subjects undergoing intravenous infusions (54 vs. 46%, P less than 0.001), whereas extraction percents of [3H]Iso exceeded those of [3H]NE when the tracers were infused intra-arterially. Regardless of the infusion site, FASO was positively correlated with FBF (r = 0.44, P less than 0.005). Nitroprusside increased FBF and FASO, and methoxamine decreased FBF and FASO. When the tracers were added to whole blood, 89% of [3H]NE and 83% of [3H]Iso remained in plasma after 1 min; although no further loss of [3H]NE occurred over time, only 60% of the added [3H]Iso remained in plasma by 20 min. The results indicate that regional NE spillover is flow dependent, complicating inferences about regional sympathoneural activity. Intra-arterial infusion of [3H]NE results in higher estimates of regional NE spillover than does intravenous infusion of the tracer.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. Jacob, F. Costa, J. R. Shannon, R. M. Robertson, M. Wathen, M. Stein, I. Biaggioni, A. Ertl, B. Black, and D. Robertson The Neuropathic Postural Tachycardia Syndrome N. Engl. J. Med., October 5, 2000; 343(14): 1008 - 1014. [Abstract] [Full Text] [PDF]

				D. S. Goldstein, A. Golczynska, J. Stuhlmuller, C. Holmes, R. F. Rea, E. Grossman, and J. Lenders A Test of the "Epinephrine Hypothesis" in Humans Hypertension, January 1, 1999; 33(1): 36 - 43. [Abstract] [Full Text] [PDF]

				I. J. Kopin, B. Rundqvist, P. Friberg, J. Lenders, D. S. Goldstein, and G. Eisenhofer Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R165 - R173. [Abstract] [Full Text] [PDF]

				G. Eisenhofer, P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler Cardiac Sympathetic Nerve Function in Congestive Heart Failure Circulation, May 1, 1996; 93(9): 1667 - 1676. [Abstract] [Full Text]

				G. A. Rongen, J. W.M. Lenders, J. Lambrou, J. J. Willemsen, H. Van Belle, T. Thien, and P. Smits Presynaptic Inhibition of Norepinephrine Release From Sympathetic Nerve Endings by Endogenous Adenosine Hypertension, April 1, 1996; 27(4): 933 - 938. [Abstract] [Full Text]